A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens

Overview of attention for article published in Frontiers in immunology, May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 38,508 followers.

RT @vaxresearch: https://t.co/mpFNR8FyRO HIV paper, first author, Dr Sven Kratochvil Group Lead, Professor Robin Shattock, Imperial College…

RT @FrontImmunol: A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody… http…

A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody… https://t.co/5d7tcK9JLp

RT @HIVEnterprise: Scientists @imperialcollege show that an accelerated 6-month HIV #vaccine regimen induces systemic and mucosal IgG: http…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.